Search results for "Bioengineering"

showing 10 items of 1963 documents

Candida blood stream infections observed between 2011 and 2016 in a large Italian University Hospital: A time-based retrospective analysis on epidemi…

2019

Candida bloodstream infection (BSI) represents a growing infective problem frequently associated to biofilm production due to the utilization of intravascular devices. Candida species distribution (n = 612 strains), their biofilm production and hospital antifungal drug consumption were evaluated in different wards of a tertiary care academic hospital in Italy during the years 2011–2016. In the considered time window, an increasing number of Candida BSI (p = 0.005) and of biofilm producing strains were observed (p<0.0001). Although C. albicans was the species more frequently isolated in BSI with a major biofilm production, an increased involvement of non-albicans species was reported, partic…

0301 basic medicineAntifungal AgentsTime FactorsAntifungal drugYeast and Fungal ModelsPathology and Laboratory Medicinelaw.inventionHospitals Universitychemistry.chemical_compound0302 clinical medicinelawAmphotericin BMedicine and Health Sciences030212 general & internal medicineAmphotericinFluconazoleCandidaFungal PathogensPrincipal Component AnalysisMultidisciplinaryAntimicrobialsQCandidiasisREukaryotaDrugsIntensive care unitHospitalsCorpus albicansIntensive Care UnitsExperimental Organism SystemsItalyMedical MicrobiologyEngineering and TechnologyMedicinePathogensResearch ArticleBiotechnologymedicine.drugCandida Candida bloodstream infection biofilm antifungal agents drug susceptibilityCathetersScience030106 microbiologyBioengineeringMycologyMicrobial Sensitivity TestsResearch and Analysis MethodsMicrobiologyMicrobiology03 medical and health sciencesMicrobial ControlmedicineCandida AlbicansHumansMicrobial PathogensRetrospective StudiesPharmacologyVoriconazoleAntifungalsbusiness.industryOrganismsFungiBiofilmBiology and Life SciencesYeastHealth CarechemistryHealth Care FacilitiesBiofilmsAnimal StudiesMedical Devices and EquipmentAntimicrobial ResistanceCaspofunginbusinessFluconazolePLOS ONE
researchProduct

Time-kill assays of amphotericin B plus anidulafungin against Candida tropicalis biofilms formed on two different biomaterials.

2017

Purpose: To determine the fungicidal activity by time-killing assays of amphotericin B (AMB) combined with anidulafungin (ANF) against biofilms of 2 clinical isolates of Candida tropicalis and the reference strain ATCC® 750, developed on polytetrafluoroethylene (PTFE) and titanium, using the CDC Biofilm Reactor (CBR) as an in vitro model. Methods: Biofilms were developed for 24 hours on the disk surfaces and then exposed to AMB (40 mg/L), ANF (8 mg/L), alone and combined. At predetermined time points after drug exposure, biofilms were removed from the disk surface by vortexing-sonication to quantify viable biofilm cells. Results: Drug activity was dependent on strain and time. After exposur…

0301 basic medicineAntifungalmedicine.drug_class030106 microbiologyBiomedical EngineeringMedicine (miscellaneous)BioengineeringAnidulafunginMicrobiologyBiomaterialsCandida tropicalis03 medical and health sciencesAmphotericin BAmphotericin BmedicineCandida tropicalisTitaniumbiologyStrain (chemistry)ChemistryBiofilmBiomaterialGeneral Medicinebiology.organism_classificationBiofilmsAnidulafunginPTFEAntagonismmedicine.drugThe International journal of artificial organs
researchProduct

Risk Assessment of Hip Fracture Based on Machine Learning

2020

[EN] Identifying patients with high risk of hip fracture is a great challenge in osteoporosis clinical assessment. Bone Mineral Density (BMD) measured by Dual-Energy X-Ray Absorptiometry (DXA) is the current gold standard in osteoporosis clinical assessment. However, its classification accuracy is only around 65%. In order to improve this accuracy, this paper proposes the use of Machine Learning (ML) models trained with data from a biomechanical model that simulates a sideways-fall. Machine Learning (ML) models are models able to learn and to make predictions from data. During a training process, ML models learn a function that maps inputs and outputs without previous knowledge of the probl…

0301 basic medicineArticle SubjectProcess (engineering)Computer scienceQH301-705.5INGENIERIA MECANICAmedia_common.quotation_subjectOsteoporosisBiomedical EngineeringMedicine (miscellaneous)030209 endocrinology & metabolismBioengineeringMachine learningcomputer.software_genreRisk AssessmentMachine Learning03 medical and health sciencesHip Fracture0302 clinical medicinemedicine03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edadesSensitivity (control systems)Biology (General)media_commonHip fractureVariablesbusiness.industryGold standard (test)medicine.diseaseRandom forest030104 developmental biologyArtificial intelligenceRisk assessmentbusinessLENGUAJES Y SISTEMAS INFORMATICOScomputerTP248.13-248.65Research ArticleBiotechnologyApplied Bionics and Biomechanics
researchProduct

AMD3100: A Versatile Platform for CXCR4 Targeting 68 Ga-Based Radiopharmaceuticals

2016

International audience; CXCR4 is a G protein-coupled receptor (GPCR), which is overexpressed in numerous diseases, particularly in multiple cancers. Therefore, this receptor represents a valuable target for imaging and therapeutic purposes. Among the different approaches, which were developed for CXCR4 imaging, a CXCR4 antagonist biscyclam system (AMD3100, also called Mozobil), currently used in the clinic for the mobilization of hematopoietic stem cells, was radiolabeled with different radiometals such as 62Zn, 64Cu, 67Ga, or 99mTc. However, cyclam is not an ideal chelator for most of these radiometals, and could lead to the release of the radionuclide in vivo. In the current study, a new …

0301 basic medicineBenzylaminesReceptors CXCR4Biomedical EngineeringPharmaceutical ScienceGallium Radioisotopes[SDV.CAN]Life Sciences [q-bio]/CancerBioengineeringPharmacologyCyclamsCXCR4[ CHIM ] Chemical Sciences[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHeterocyclic CompoundsIn vivoCyclamHumans[CHIM]Chemical SciencesMoietyReceptorG protein-coupled receptorPharmacologyCXCR4CXCR4 antagonistChemistryOrganic Chemistry3. Good health030104 developmental biology030220 oncology & carcinogenesisCancer researchStem cellBiotechnology
researchProduct

Ochrobactrum sp. MPV1 from a dump of roasted pyrites can be exploited as bacterial catalyst for the biogenesis of selenium and tellurium nanoparticles

2017

Bacteria have developed different mechanisms for the transformation of metalloid oxyanions to non-toxic chemical forms. A number of bacterial isolates so far obtained in axenic culture has shown the ability to bioreduce selenite and tellurite to the elemental state in different conditions along with the formation of nanoparticles—both inside and outside the cells—characterized by a variety of morphological features. This reductive process can be considered of major importance for two reasons: firstly, toxic and soluble (i.e. bioavailable) compounds such as selenite and tellurite are converted to a less toxic chemical forms (i.e. zero valent state); secondly, chalcogen nanoparticles have att…

0301 basic medicineBioconversionIron CompoundOchrobactrum sp. MPV1lcsh:QR1-502Metal NanoparticlesSelenious AcidSettore BIO/19 - Microbiologia GeneraleApplied Microbiology and BiotechnologyArsenicalslcsh:MicrobiologyCatalysiRare earth oxyanionschemistry.chemical_compoundAerobic selenite reductionArsenicalChalcogen metalloidsSettore CHIM/02 - Chimica FisicaMineralsAerobic tellurite reductionbiologyAxenic CultureAerobiosiAerobiosisBiochemistryItalyMetalloidTelluriumBiotechnologyBacterial-metalloid interactionSulfidechemistry.chemical_elementBioengineeringSulfidesOchrobactrumCatalysisChalcogen metalloidCatalysis03 medical and health sciencesChalcogenOchrobactrumMetal NanoparticleSeleniumBiosynthesisBacterial-metalloid interactionsMineralRare earth oxyanionResearchBiogenically synthesized nanoparticlesBiogenically synthesized nanoparticlebiology.organism_classificationCombinatorial chemistryMicroscopy Electron030104 developmental biologychemistryBacteriaSeleniumIron CompoundsMicrobial Cell Factories
researchProduct

Biosynthesis of selenium-nanoparticles and -nanorods as a product of selenite bioconversion by the aerobic bacterium Rhodococcus aetherivorans BCP1

2018

The wide anthropogenic use of selenium compounds represents the major source of selenium pollution world- wide, causing environmental issues and health concerns. Microbe-based strategies for metal removal/recovery have received increasing interest thanks to the association of the microbial ability to detoxify toxic metal/ metalloid polluted environments with the production of nanomaterials. This study investigates the tolerance and the bioconversion of selenite (SeO32−) by the aerobically grown Actinomycete Rhodococcus aetherivorans BCP1 in association with its ability to produce selenium nanoparticles and nanorods (SeNPs and SeNRs). The BCP1 strain showed high tolerance towards SeO32− with…

0301 basic medicineBioconversionStatic Electricity030106 microbiologychemistry.chemical_elementBioengineeringSelenious AcidSettore BIO/19 - Microbiologia GeneraleSelenium pollutionSelenium03 medical and health sciencesMinimum inhibitory concentrationchemistry.chemical_compoundNanoparticleBiosynthesisRhodococcusParticle SizeSelenite Rhodococcus aetherivorans Selenium nanoparticles Selenium nanorods Biogenic nanostructuresSelenium nanorodMolecular BiologyNanotubesbiologyBiogenic nanostructureRhodococcus aetherivoranSpectrometry X-Ray EmissionGeneral Medicinebiology.organism_classificationDynamic Light ScatteringSelenium nanoparticleBacteria AerobicNanotube030104 developmental biologychemistryBiochemistry13. Climate actionSelenious AcidSeleniteNanoparticlesMetalloidRhodococcusSeleniumRhodococcuBiotechnologyNew Biotechnology
researchProduct

Dextran-based therapeutic nanoparticles for hepatic drug delivery.

2016

Aim: Evaluation of dextran-based nanoparticles (DNP) as a drug delivery system to target myeloid cells of the liver. Materials &amp; methods: DNP were synthesized and optionally PEGylated. Their toxicity and cellular uptake were studied in vitro. Empty and siRNA-carrying DNP were tested in vivo with regard to biodistribution and cellular uptake. Results: In vitro, DNP were taken up by cells of the myeloid lineage without compromising their viability. In vivo, empty and siRNA-carrying DNP distributed to the liver where a single treatment addressed approximately 70% of macrophages and dendritic cells. Serum parameters indicated no in vivo toxicity. Conclusion: DNP are multifunctional liver-s…

0301 basic medicineBiodistributionMaterials scienceCell SurvivalSurface PropertiesBiomedical EngineeringMedicine (miscellaneous)Antigens Differentiation Myelomonocyticchemical and pharmacologic phenomenaBioengineering02 engineering and technologyDevelopmentPharmacologyPolyethylene Glycols03 medical and health scienceschemistry.chemical_compoundMiceIn vivoAntigens CDAnimalsHumansGeneral Materials ScienceTissue DistributionParticle SizeRNA Small InterferingDrug CarriersMice Inbred BALB Corganic chemicalsMacrophageshemic and immune systemsDextransDendritic cell3T3 CellsDendritic Cells021001 nanoscience & nanotechnology030104 developmental biologyDextranRAW 264.7 CellschemistryLiverDrug deliveryToxicityPEGylationNanoparticles0210 nano-technologyDrug carrierNanomedicine (London, England)
researchProduct

Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles

2016

Identifying intended or accidental cellular targets for drug delivery systems is highly relevant for evaluating therapeutic and toxic effects. However, limited knowledge exists on the distribution of nano- and micrometer-sized carrier systems at the cellular level in different organs. We hypothesized that clinically relevant carrier materials, differing in composition and size, are able to target distinct myeloid cell subsets that control inflammatory processes, such as macrophages, neutrophils, monocytes and dendritic cells. Therefore, we analyzed the biodistribution and in vivo cellular uptake of intravenously injected poly(N-(2-hydroxypropyl) methacrylamide) polymers, PEGylated liposomes…

0301 basic medicineBiodistributionMyeloidPolymersCellBiophysicsMice NudeCapsulesBioengineeringSpleen02 engineering and technologyFlow cytometryBiomaterialsMice03 medical and health sciencesNanocapsulesIn vivoMaterials TestingmedicineAnimalsMyeloid CellsTissue DistributionMolecular Targeted TherapyMicrobubblesmedicine.diagnostic_testbusiness.industryMacrophages021001 nanoscience & nanotechnology3. Good healthCell biologyVisceraNanomedicine030104 developmental biologymedicine.anatomical_structureOrgan SpecificityMechanics of Materials2023 OA procedureLiposomesImmunologyDrug deliveryCeramics and CompositesMicrobubblesTargeted delivery0210 nano-technologybusinessBiomaterials
researchProduct

Biological and anticancer properties of Inonotus obliquus extracts

2018

Abstract Inonotus obliquus (IO) has traditionally been used in folk medicine in the treatment of gastrointestinal cancer, cardiovascular disease and diabetes. The aim of our study was to evaluate the biological and metabolic properties of IO extracts. Free radical scavenging properties, inhibition of the activity of xanthine oxidase (XOi), induction of reactive oxygen species (ROS) production, cell viability and expression of superoxide dismutase (SOD1), catalase (CAT) and KI67 mRNA in the human colorectal adenocarcinoma (Caco-2) and normal human skin fibroblast (BJ) cell lines were measured. It was found that 80% ethanol extract of IO exhibited the highest properties inhibiting the activit…

0301 basic medicineBioengineeringApplied Microbiology and BiotechnologyBiochemistrySuperoxide dismutase03 medical and health scienceschemistry.chemical_compoundmedicineViability assayXanthine oxidasechemistry.chemical_classificationReactive oxygen speciesbiologyInonotus obliquusbiology.organism_classificationMolecular biology030104 developmental biologyAnticancerchemistryMechanism of actionCatalaseCell culturebiology.proteinInonotus obliquusmedicine.symptomAntioxidantAntiproliferativeProcess Biochemistry
researchProduct

Genomic characterization of Defluviitoga tunisiensis L3, a key hydrolytic bacterium in a thermophilic biogas plant and its abundance as determined by…

2016

The genome sequence of Defluviitoga tunisiensis L3 originating from a thermophilic biogas-production plant was established and recently published as Genome Announcement by our group. The circular chromosome of D. tunisiensis L3 has a size of 2,053,097bp and a mean GC content of 31.38%. To analyze the D. tunisiensis L3 genome sequence in more detail, a phylogenetic analysis of completely sequenced Thermotogae strains based on shared core genes was performed. It appeared that Petrotoga mobilis DSM 10674(T), originally isolated from a North Sea oil-production well, is the closest relative of D. tunisiensis L3. Comparative genome analyses of P. mobilis DSM 10674(T) and D. tunisiensis L3 showed …

0301 basic medicineBioengineeringBiologyApplied Microbiology and BiotechnologyGenomeComparative genome analyses03 medical and health sciencesThermophilic BacteriaGeneGeneticsWhole genome sequencingThermotogaeBacteriaThermophileGeneral Medicinebiology.organism_classification030104 developmental biologyMetagenomicsBiofuelsThermotogaeMetagenomeSugar utilizationGC-contentGenome BacterialBiotechnologyArchaea
researchProduct